Literature DB >> 7902571

17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product.

S Matsuda1, Y Kadowaki, M Ichino, T Akiyama, K Toyoshima, T Yamamoto.   

Abstract

We report here the physical and functional interaction of estrogen with the ErbB2 protein p185c-erbB2. The ErbB2 protein immunoprecipitated from estrogen-treated [10(-8) to 10(-6) M 17 beta-estradiol (E2)] RC cells showed higher autophosphorylation activity than that from untreated cells. Likewise autophosphorylation activity of ErbB2 protein from untreated cells was stimulated in vitro by E2. In addition, E2 treatment induced down-regulation of ErbB2 protein from the detergent-soluble fraction of the RC cells within 15 min. E2 also induced morphological transformation of the RC cells but not of the parental NIH 3T3 cells, which express little c-erbB2 under the same experimental conditions. This morphological transformation of RC cells was reversed by tamoxifen. However, E2 treatment did not induce anchorage-independent growth of RC cells. Scatchard analysis revealed E2 binding to the ErbB2 protein on RC cells; the Kd value was 2.7 nM. E2 did not bind appreciably to the parental NIH 3T3 cells or cells expressing an ErbB2 protein lacking most of its extracellular domain. These data suggest that estrogen plays an important role in ErbB2-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902571      PMCID: PMC47866          DOI: 10.1073/pnas.90.22.10803

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

Authors:  T Akiyama; C Sudo; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

2.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.

Authors:  S Green; P Walter; V Kumar; A Krust; J M Bornert; P Argos; P Chambon
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

3.  The neu oncogene encodes an epidermal growth factor receptor-related protein.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

4.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

5.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

10.  Detection of the ligand activity of the c-erbB-2 protein in calf serum.

Authors:  R J Shan; S Matsuda; M Ichino; T Yamamoto
Journal:  Jpn J Cancer Res       Date:  1992-01
View more
  19 in total

1.  Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium.

Authors:  T Improta-Brears; A R Whorton; F Codazzi; J D York; T Meyer; D P McDonnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breast.

Authors:  H Inaji; H Koyama; K Motomura; S Noguchi
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors.

Authors:  A M Norfleet; C H Clarke; B Gametchu; C S Watson
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

4.  Oestradiol-induced relaxation of rabbit basilar artery by inhibition of voltage-dependent Ca channels through GTP-binding protein.

Authors:  R Ogata; Y Inoue; H Nakano; Y Ito; K Kitamura
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

5.  Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development.

Authors:  Y J Ma; D F Hill; K E Creswick; M E Costa; A Cornea; M N Lioubin; G D Plowman; S R Ojeda
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

Review 6.  Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.

Authors:  M De Bortoli; C Dati
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

7.  Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.

Authors:  Mary S Sakla; Nader S Shenouda; Pete J Ansell; Ruth S Macdonald; Dennis B Lubahn
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

Review 8.  Studying environmental influences and breast cancer risk: suggestions for an integrated population-based approach.

Authors:  R Millikan; E DeVoto; B Newman; D Savitz
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

9.  A synthetic oestrogen antagonist, tamoxifen, inhibits oestrogen-induced transcriptional, but not post-transcriptional, regulation of gene expression.

Authors:  Y Arao; E Yamamoto; N Miyatake; Y Ninomiya; T Umehara; H Kawashima; S Masushige; T Hasegawa; S Kato
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

Review 10.  The need for epidemiologic studies of in-situ carcinoma of the breast.

Authors:  R Millikan; L Dressler; J Geradts; M Graham
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.